<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26870944</PMID><DateCompleted><Year>2016</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Luteoloside Acts as 3C Protease Inhibitor of Enterovirus 71 In Vitro.</ArticleTitle><Pagination><StartPage>e0148693</StartPage><MedlinePgn>e0148693</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0148693</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0148693</ELocationID><Abstract><AbstractText>Luteoloside is a member of the flavonoids family that exhibits several bioactivities including anti-microbial and anti-cancer activities. However, the antiviral activity of luteoloside against enterovirus 71 (EV71) and the potential mechanism(s) responsible for this effect remain unknown. In this study, the antiviral potency of luteoloside against EV71 and its inhibitory effects on 3C protease activity were evaluated. First, we investigated the cytotoxicity of luteoloside against rhabdomyosarcoma (RD) cells, which was the cell line selected for an in vitro infection model. In a subsequent antiviral assay, the cytopathic effect of EV71 was significantly and dose-dependently relieved by the administration of luteoloside (EC50 = 0.43 mM, selection index = 5.3). Using a plaque reduction assay, we administered luteoloside at various time points and found that the compound reduced EV71 viability in RD cells rather than increasing defensive mobilization or viral absorption. Moreover, biochemical studies focused on VP1 (a key structural protein of EV71) mRNA transcript and protein levels also revealed the inhibitory effects of luteoloside on the EV71 viral yield. Finally, we performed inhibition assays using luteoloside to evaluate its effect on recombinant 3C protease activity. Our results demonstrated that luteoloside blocked 3C protease enzymatic activity in a dose-dependent manner (IC50 = 0.36 mM) that was similar to the effect of rutin, which is a well-known C3 protease inhibitor. Collectively, the results from this study indicate that luteoloside can block 3C protease activity and subsequently inhibit EV71 production in vitro.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Zeyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Zhipeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhenzhong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015853">Cysteine Proteinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005960">Glucosides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>98J6XDS46I</RegistryNumber><NameOfSubstance UI="C066408">luteolin-7-glucoside</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>KUX1ZNC9J2</RegistryNumber><NameOfSubstance UI="D047311">Luteolin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015853" MajorTopicYN="N">Cysteine Proteinase Inhibitors</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005960" MajorTopicYN="N">Glucosides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047311" MajorTopicYN="N">Luteolin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008516" MajorTopicYN="N">Medicine, Chinese Traditional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>All authors are employed by Jiangsu Kanion Pharmaceutical Co., Ltd. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>2</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26870944</ArticleId><ArticleId IdType="pmc">PMC4752227</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0148693</ArticleId><ArticleId IdType="pii">PONE-D-15-35543</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>He L, Xu X, Li Y, Li C, Zhu Y, Yan H, et al. (2013) Transcriptome analysis of buds and leaves using 454 pyrosequencing to discover genes associated with the biosynthesis of active ingredients in Lonicera japonica Thunb. PLoS One 25: e62922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3636143</ArticleId><ArticleId IdType="pubmed">23638167</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu AL, Liu B, Qin HL, Lee SM, Wang YT, Du GH. (2008) Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med 74: 847&#x2013;851. 10.1055/s-2008-1074558</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2008-1074558</ArticleId><ArticleId IdType="pubmed">18553272</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong J, Li S, Wang W, Hong Y, Tang K, Luo Q. (2013) Screening and identification of the antibacterial bioactive compounds from Lonicera japonica Thunb. leaves. Food Chem 138: 327&#x2013;333. 10.1016/j.foodchem.2012.10.127</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2012.10.127</ArticleId><ArticleId IdType="pubmed">23265495</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Tam KY, Meng M, Shan J, Wang S, Ju W, et al. (2015) Pharmacokinetics screening for multi-components absorbed in the rat plasma after oral administration of traditional Chinese medicine Flos Lonicerae Japonicae-Fructus Forsythiae herb couple by sequential negative and positive ionization ultra-high-performance liquid chromatography/tandem triple quadrupole mass spectrometric detection. J Chromatogr A 1376: 84&#x2013;97. 10.1016/j.chroma.2014.12.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chroma.2014.12.018</ArticleId><ArticleId IdType="pubmed">25533397</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakashima S, Oda Y, Nakamura S, Liu J, Onishi K, Kawabata M, et al. (2015) Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna). Bioorg Med Chem Lett 25: 2702&#x2013;2706. 10.1016/j.bmcl.2015.04.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2015.04.052</ArticleId><ArticleId IdType="pubmed">25987378</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Gu S, Guo L, Xia X, Zhang H, Wang J. Preparative separation of five flavones from flowers of Polygonum cuspidatum by high-speed countercurrent chromatography. J Sep Sci 37: 1703&#x2013;1709. 10.1002/jssc.201400153</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jssc.201400153</ArticleId><ArticleId IdType="pubmed">24753452</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan SH, Wang YY, Lu J, Zheng YL, Wu DM, Li MQ, et al. (2014) Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome. PLoS One 9: e89961 10.1371/journal.pone.0089961</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089961</ArticleId><ArticleId IdType="pmc">PMC3935965</ArticleId><ArticleId IdType="pubmed">24587153</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu F, Li Z, He L, Wang D. (2013) HPLC-ESI-MS/MS analysis and pharmacokinetics of luteoloside, a potential anticarcinogenic component isolated from Lonicera japonica, in beagle dogs. Biomed Chromatogr 27: 311&#x2013;317. 10.1002/bmc.2793</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bmc.2793</ArticleId><ArticleId IdType="pubmed">22865633</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti C, Tomao P, Genovese D, Desideri N, Stein ML, Orsi N. (1992) Mechanismof action of the antirhinovirus flavanoid 4&#x2019;,6-dicyanoflavan. Antimicrob Agents Chemother 36: 95&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189234</ArticleId><ArticleId IdType="pubmed">1317152</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti C, Genovese D, Santoro R, Stein ML, Orsi N, Fiore L. (1990) Activities and mechanisms of action of halogen-substituted flavanoids against poliovirus type 2 infection in vitro. Antimicrob Agents Chemother 34: 460&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC171615</ArticleId><ArticleId IdType="pubmed">2159258</ArticleId></ArticleIdList></Reference><Reference><Citation>Genovese D, Conti C, Tomao P, Desideri N, Stein ML, Catone S, et al. (1995) Effect of chloro-, cyano-, and amidino-substituted flavanoids on enterovirus infection in vitro. Antiviral Res 27: 123&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">7486950</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval IV, Carrasco L. (1997) Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. J Virol 71: 4679&#x2013;4693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191690</ArticleId><ArticleId IdType="pubmed">9151862</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrijsen R, Everaert L, Van Hoof LM, Vlietinck AJ, Vanden Berghe DA, Boey&#xe9; A. (1987) The poliovirus-induced shut-off of cellular protein synthesis persists in the presence of 3-methylquercetin, a flavonoid which blocks viral protein and RNA synthesis. Antiviral Res 7: 35&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">3026245</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, Aoki Y, Suto A, Ootani K, Katsushima N, Itagaki T, et al. (2009) Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine 27: 3153&#x2013;3158. 10.1016/j.vaccine.2009.03.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.03.060</ArticleId><ArticleId IdType="pubmed">19446185</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zou G, Xia A, Wang X, Cai J, Gao Q, et al. (2015) Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis. Virol J 12: 83 10.1186/s12985-015-0308-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0308-2</ArticleId><ArticleId IdType="pmc">PMC4464242</ArticleId><ArticleId IdType="pubmed">26036928</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Pallansch MA. (1995) Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 39: 195&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Liu X, Ma Y, Sun Z, Yang Y, Jin Q, et al. (2010) The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol 84: 805&#x2013;8061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung HC, Chen TC, Fang MY, Yen KJ, Shih SR, Hsu JT, et al. (2010) Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid. J Antimicrob Chem 65: 676&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110181</ArticleId><ArticleId IdType="pubmed">20089540</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor PD. (1990) Antigenic structure of picornaviruses. Curr Top Microbiol Immunol 161: 121&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">2169382</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Jiang B, Xu M, Dai X, Purdy MA, Meng J. (2014) Identification of specific antigenic epitope at N-terminal segment of enterovirus 71 (EV-71) VP1 protein and characterization of its use in recombinant form for early diagnosis of EV-71 infection. Virus Res 189: 248&#x2013;253. 10.1016/j.virusres.2014.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.06.003</ArticleId><ArticleId IdType="pmc">PMC4698801</ArticleId><ArticleId IdType="pubmed">24952304</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Maher K, Kilpatrick DR, Pallansch MA. (1999) Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol 73: 1941&#x2013;1948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104435</ArticleId><ArticleId IdType="pubmed">9971773</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Nix WA, Maher K, Pallansch MA. (2003) Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J Clin Virol 26: 375&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pubmed">12637088</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin YX, Ou ZY, Xu Y, Zhou R, Xia HM. (2014) Phylogenetic analysis of the VP1 gene of Enterovirus 71 in Guangzhou during the high occurrence period of 2008. Virus Genes 48: 538&#x2013;542. 10.1007/s11262-014-1046-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-014-1046-z</ArticleId><ArticleId IdType="pubmed">24515837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung HC, Wang HC, Shih SR, Teng IF, Tseng CP, Hsu JT. (2011) Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J Infect Dis 203: 1784&#x2013;1790. 10.1093/infdis/jir174</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir174</ArticleId><ArticleId IdType="pubmed">21536800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuyumcu-Martinez NM, Joachims M, Lloyd RE. (2002) Efficient cleavage of ribosome-associated poly(A)-binding protein by enterovirus 3C protease. J Virol 76: 2062&#x2013;2074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC135927</ArticleId><ArticleId IdType="pubmed">11836384</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Sun Z, Liu X, Jin Q, He B, Wang J. (2011) Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J Virol 85: 8811&#x2013;8818. 10.1128/JVI.00447-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00447-11</ArticleId><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng KF, Li ML, Hung CT, Shih SR. (2009) Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog 5: e1000593 10.1371/journal.ppat.1000593</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000593</ArticleId><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, Hsu TA, Chen TC, Chang SC, Lee JC, Chen CC, et al. (2002) The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 293: 386&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TC, Weng KF, Chang SC, Lin JY, Huang PN, Shih SR. (2008) Development of antiviral agents for enteroviruses. J Antimicrob Chemother 62: 1169&#x2013;1173. 10.1093/jac/dkn424</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkn424</ArticleId><ArticleId IdType="pubmed">18931391</ArticleId></ArticleIdList></Reference><Reference><Citation>Binford SL, Weady PT, Maldonado F, Brothers MA, Matthews DA, Patick AK. In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother 51: 4366&#x2013;4373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2167992</ArticleId><ArticleId IdType="pubmed">17908951</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Chen SJ, Hakimelahi GH, Liu HJ, Tseng CT, Shia KS. (2004) Selective human enterovirus and rhinovirus inhibitors: An overview of capsid-binding and protease-inhibiting molecules. Med Res Rev 24: 449&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7168432</ArticleId><ArticleId IdType="pubmed">15170592</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YJ, Chang YC, Hsiao NW, Hsieh JL, Wang CY, Kung SH, et al. Fisetin and rutin as 3C protease inhibitors of enterovirus A71. J Virol Methods 182: 93&#x2013;98. 10.1016/j.jviromet.2012.03.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.03.020</ArticleId><ArticleId IdType="pubmed">22465253</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Liu Y, Hou X, Peng H, Zhang L, Jiang Q, et al. (2013) Chlorogenic acid inhibits the replication and viability of enterovirus 71 in vitro. PLoS One 8: e76007 10.1371/journal.pone.0076007</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076007</ArticleId><ArticleId IdType="pmc">PMC3786884</ArticleId><ArticleId IdType="pubmed">24098754</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi X, Zhang X, Wang B, Wang T, Wang J, Huang H, et al. (2013) The interplays between autophagy and apoptosis induced by enterovirus 71. PLoS One 8: e56966 10.1371/journal.pone.0056966</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0056966</ArticleId><ArticleId IdType="pmc">PMC3577684</ArticleId><ArticleId IdType="pubmed">23437282</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJM, Muench H. (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27: 493&#x2013;497.</Citation></Reference><Reference><Citation>Massignan T, Stewart RS, Biasini E, Solomon IH, Bonetto V, Chiesa R, et al. (2010) A novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion protein. J Biol Chem 285: 7752&#x2013;7765. 10.1074/jbc.M109.064949</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.064949</ArticleId><ArticleId IdType="pmc">PMC2844219</ArticleId><ArticleId IdType="pubmed">19940127</ArticleId></ArticleIdList></Reference><Reference><Citation>Spouge JL. (1992) Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates. Proc Natl Acad Sci USA 89: 7581&#x2013;7585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC49754</ArticleId><ArticleId IdType="pubmed">1323844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Wang C, Xu L, Chen X, Wang W, Yang G, et al. (2013) A laboratory evaluation of medicinal herbs used in china for the treatment of hand, foot, and mouth disease. Evid Based Complement Alternat Med 2013: 504563 10.1155/2013/504563</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/504563</ArticleId><ArticleId IdType="pmc">PMC3608275</ArticleId><ArticleId IdType="pubmed">23554831</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang X, Pan H, Li M, Miao X, Ding H. (2011) Lonicera japonica Thunb.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol 138: 1&#x2013;21. 10.1016/j.jep.2011.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2011.08.016</ArticleId><ArticleId IdType="pmc">PMC7127058</ArticleId><ArticleId IdType="pubmed">21864666</ArticleId></ArticleIdList></Reference><Reference><Citation>Kok TW, Pryor T, Payne L. (1998) Comparison of rhabdomyosarcoma, buffalo green monkey kidney epithelial, A549 (human lung epithelial) cells and human embryonic lung fibroblasts for isolation of enteroviruses from clinical samples. J Clin Virol 11: 61&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">9784144</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W, Li X, Hou X, Peng H, Jiang Q, Shi M, et al. (2012) Differential apoptosis gene expressions of rhabdomyosarcoma cells in response to enterovirus 71 infection. BMC Infect Dis 12: 327 10.1186/1471-2334-12-327</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-12-327</ArticleId><ArticleId IdType="pmc">PMC3536580</ArticleId><ArticleId IdType="pubmed">23191987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjell&#xe9;n L. (1985) A hypothesis accounting for the effect of the host cell on neutralization-resistant virus. J Gen Virol 66: 2279&#x2013;2283.</Citation><ArticleIdList><ArticleId IdType="pubmed">2995563</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Fan P, Jin J, Su W, An D, Xu L, et al. (2013) Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virol J 10: 250 10.1186/1743-422X-10-250</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-250</ArticleId><ArticleId IdType="pmc">PMC3765843</ArticleId><ArticleId IdType="pubmed">23919614</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Du J, Wu Z, Jin Q. (2013) Quinacrine impairs enterovirus 71 RNA replication by preventing binding of polypyrimidine-tract binding protein with internal ribosome entry sites. PLoS One 8: e52954 10.1371/journal.pone.0052954</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052954</ArticleId><ArticleId IdType="pmc">PMC3536785</ArticleId><ArticleId IdType="pubmed">23301007</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Su W, Jin J, Chen J, Li X, Zhang X, et al. (2014) Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening. Viruses 6: 2778&#x2013;2795. 10.3390/v6072778</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6072778</ArticleId><ArticleId IdType="pmc">PMC4113793</ArticleId><ArticleId IdType="pubmed">25036464</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, He YQ, Yi LN, Zan H, Kung HF, He ML. (2011) Viral kinetics of Enterovirus 71 in human abdomyosarcoma cells. World J Gastroenterol 17: 4135&#x2013;4142. 10.3748/wjg.v17.i36.4135</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v17.i36.4135</ArticleId><ArticleId IdType="pmc">PMC3203367</ArticleId><ArticleId IdType="pubmed">22039330</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Yang Y, Xu Y, Ma C, Qin C, Zhang L. (2011) Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication. Virol J 8: 483 10.1186/1743-422X-8-483</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-483</ArticleId><ArticleId IdType="pmc">PMC3212826</ArticleId><ArticleId IdType="pubmed">22029605</ArticleId></ArticleIdList></Reference><Reference><Citation>E&#x15f;anu V, Prahoveanu E, Cri&#x15f;an I, Cioca A. (1981) The effect of an aqueous propolis extract, of rutin and of a rutin-quercetin mixture on experimental influenza virus infection in mice. Virologie 32: 213&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">7303493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MS AbuBakar S. (2011) In vitro antiviral activity of Fisetin, Rutin and Naringenin against Dengue virus type-2. J Med Plants Res 5: 5534&#x2013;5539.</Citation></Reference><Reference><Citation>Dragovich PS, Webber SE, Babine RE, Fuhrman SA, Patick AK, Matthews DA, et al. (1998) Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies. J Med Chem 41: 2819&#x2013;2834.</Citation><ArticleIdList><ArticleId IdType="pubmed">9667971</ArticleId></ArticleIdList></Reference><Reference><Citation>Patick AK, Binford SL, Brothers MA, Jackson RL, Ford CE, Diem MD, et al. (1999) In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother 43: 2444&#x2013;2450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89498</ArticleId><ArticleId IdType="pubmed">10508022</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>